Literature DB >> 3700977

Thyroid hormone modulation of VIP's induced salivary secretion in the submaxillary glands of rats.

O R Tumilasci, A B Houssay, N E Sosto, C V Paz, V Varela.   

Abstract

The effect of changes in thyroid function upon vasoactive intestinal peptide (VIP) induced secretion of saliva were studied in male Wistar rats. Hyperthyroidism was induced by the sc administration every 12 h of 10 micrograms/100 g bw of I-triiodothyronine; hypothyroidism was induced by surgical thyroidectomy 2 weeks before the experiments. Preganglionar parasympathetic denervation was induced by sectioning the chorda tympani on the left side. The dose-response curves to increasing doses of VIP showed in the hypothyroid animals increased salivary secretion, while in the hyperthyroid ones the dose-response to the drug was reduced. This effect was seen on both sides, the denervated and the control ones. In the denervated glands there was a marked hypersensitivity to the administration of VIP producing greater responses with the same doses, in the 3 groups of animals. The negative modulation by thyroid hormones of the salivary response to VIP administration is compared with the positive modulation they induce in the salivary response to beta-adrenergic and cholinergic drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700977     DOI: 10.1007/bf03348063

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in salivary glands.

Authors:  J Wharton; J M Polak; M G Bryant; S Van Noorden; S R Bloom; A G Pearse
Journal:  Life Sci       Date:  1979-07-16       Impact factor: 5.037

2.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

3.  Modification of salivary duct electrolyte transport in rat and rabbit by physalaemin, VIP, GIP and other enterohormones.

Authors:  A R Denniss; J A Young
Journal:  Pflugers Arch       Date:  1978-08-25       Impact factor: 3.657

4.  Neuronal VIP in salivary glands: distribution and release.

Authors:  R Uddman; J Fahrenkrug; L Malm; J Alumets; R Håkanson; F Sundler
Journal:  Acta Physiol Scand       Date:  1980-09

5.  VIP-induced cyclic AMP formation in the cat submandibular gland. Potentiation by carbacholine.

Authors:  B B Fredholm; J M Lundberg
Journal:  Acta Physiol Scand       Date:  1982-01

6.  Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat.

Authors:  S R Bloom; A V Edwards
Journal:  J Physiol       Date:  1980-03       Impact factor: 5.182

7.  Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

Authors:  M G Bryant; M M Polak; I Modlin; S R Bloom; R H Albuquerque; A G Pearse
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

Review 8.  Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function.

Authors:  J Fahrenkrug
Journal:  Digestion       Date:  1979       Impact factor: 3.216

9.  Effects of thyroid function on submaxillary gland sensitivity to autonomic nervous drugs.

Authors:  O R Tumilasci; J H Medina; C H Gamper; A B Houssay
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

10.  Vasoactive intestinal peptide stimulates adrenocorticotropin release from human corticotropinoma cells in culture: interaction with arginine vasopressin and hydrocortisone.

Authors:  M C White; E F Adams; M Loizou; K Mashiter
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.